{"title":"Pathological Priming and Developmental Heterochrony as Organizing Concepts in Human iPSC Models of Autism Spectrum Disorder.","authors":"Pardis Jahandideh, Amirreza Bitaraf","doi":"10.1007/s12035-026-06252-6","DOIUrl":null,"url":null,"abstract":"<p><p>Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition in which diverse genetic risk factors converge on molecular pathways governing early brain development. Human-induced pluripotent stem cell (iPSC) and brain organoid models now permit direct interrogation of these pathways in patient-derived neural tissue and, in a subset of studies, reveal alterations in neural progenitor proliferation, cortical neurogenesis, synaptic maturation, and network excitability. A landmark iPSC study in macrocephalic idiopathic ASD introduced the concept of pathological priming of neural progenitors, durable reconfiguration of chromatin and transcriptional states that biases downstream developmental programs, and associated developmental heterochrony in neuronal gene networks, thereby linking early progenitor biology to selectively shifted trajectories of neuronal maturation and to macrostructural and functional abnormalities. This conceptual review synthesizes evidence for pathological priming and developmental heterochrony from human iPSC-derived neurons and brain organoids, focusing on the ASD subgroups in which timing mechanisms are best supported: macrocephalic idiopathic ASD, 16p11.2 and related copy number variants, and large-effect developmental regulators such as SYNGAP1. We summarize recurrent and inconsistent cellular and circuit phenotypes, evaluate multi-omic data implicating progenitor regulatory states in shaping developmental timing, and situate timing-focused mechanisms alongside synaptopathy, excitatory-inhibitory imbalance, critical-period, and neuroimmune models. We propose that disturbances in neurodevelopmental timing characterize specific ASD subgroups, particularly those with early brain overgrowth or large-effect developmental regulators, rather than ASD as a whole, and offer a useful organizing principle for integrating divergent findings and generating testable, timing-informed hypotheses for future experimental and translational work.</p>","PeriodicalId":18762,"journal":{"name":"Molecular Neurobiology","volume":"63 1","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12035-026-06252-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition in which diverse genetic risk factors converge on molecular pathways governing early brain development. Human-induced pluripotent stem cell (iPSC) and brain organoid models now permit direct interrogation of these pathways in patient-derived neural tissue and, in a subset of studies, reveal alterations in neural progenitor proliferation, cortical neurogenesis, synaptic maturation, and network excitability. A landmark iPSC study in macrocephalic idiopathic ASD introduced the concept of pathological priming of neural progenitors, durable reconfiguration of chromatin and transcriptional states that biases downstream developmental programs, and associated developmental heterochrony in neuronal gene networks, thereby linking early progenitor biology to selectively shifted trajectories of neuronal maturation and to macrostructural and functional abnormalities. This conceptual review synthesizes evidence for pathological priming and developmental heterochrony from human iPSC-derived neurons and brain organoids, focusing on the ASD subgroups in which timing mechanisms are best supported: macrocephalic idiopathic ASD, 16p11.2 and related copy number variants, and large-effect developmental regulators such as SYNGAP1. We summarize recurrent and inconsistent cellular and circuit phenotypes, evaluate multi-omic data implicating progenitor regulatory states in shaping developmental timing, and situate timing-focused mechanisms alongside synaptopathy, excitatory-inhibitory imbalance, critical-period, and neuroimmune models. We propose that disturbances in neurodevelopmental timing characterize specific ASD subgroups, particularly those with early brain overgrowth or large-effect developmental regulators, rather than ASD as a whole, and offer a useful organizing principle for integrating divergent findings and generating testable, timing-informed hypotheses for future experimental and translational work.
期刊介绍:
Molecular Neurobiology is an exciting journal for neuroscientists needing to stay in close touch with progress at the forefront of molecular brain research today. It is an especially important periodical for graduate students and "postdocs," specifically designed to synthesize and critically assess research trends for all neuroscientists hoping to stay active at the cutting edge of this dramatically developing area. This journal has proven to be crucial in departmental libraries, serving as essential reading for every committed neuroscientist who is striving to keep abreast of all rapid developments in a forefront field. Most recent significant advances in experimental and clinical neuroscience have been occurring at the molecular level. Until now, there has been no journal devoted to looking closely at this fragmented literature in a critical, coherent fashion. Each submission is thoroughly analyzed by scientists and clinicians internationally renowned for their special competence in the areas treated.